{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:50:53Z","timestamp":1769759453468,"version":"3.49.0"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>We previously described dynamic, noncontrast magnetic resonance imaging (MRI) of the female genitalia as a reproducible, nonintrusive, objective means of quantifying sexual arousal response in women without sexual difficulties. These studies showed an increase in clitoral engorgement ranging from 50 to 300% in healthy women during sexual arousal.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>This study sought to evaluate the genital arousal response in women with female sexual arousal disorder (FSAD) after administration of sildenafil and placebo. We performed a multicenter, double-blind, placebo-controlled, cross-over study to assess the clitoral engorgement response using dynamic MRI in women with FSAD after administering sildenafil and placebo followed by audiovisual sexual stimulation (AVSS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Nineteen premenopausal women with FSAD underwent two MRI sessions. Subjects were randomized to receive either (i) sildenafil 100 mg during the first session followed by placebo during the second session, or (ii) placebo followed by sildenafil. During each session, baseline MR images were obtained while subjects viewed a neutral video. Subjects then ingested sildenafil or placebo. After 30 minutes, a series of MRIs were obtained at 3-minute intervals for 10 time points while subjects viewed AVSS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>A positive sexual arousal response was achieved if clitoral volume increased \u226550% from baseline.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Thirteen of 19 (68%) subjects achieved a \u226550% increase in clitoral engorgement from baseline when administered sildenafil or placebo 30 minutes after dose administration. At 60 minutes after administration, 17\/19 (89%) subjects receiving sildenafil and 16\/19 (84%) subjects receiving placebo had responded (P value 0.3173).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Sildenafil did not augment the genital response in women with FSAD. Secondarily, a majority of women in this study did not have impaired clitoral engorgement as measured by MRI, suggesting that FSAD is not predominantly a disorder of genital engorgement.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2012.02796.x","type":"journal-article","created":{"date-parts":[[2012,5,23]],"date-time":"2012-05-23T16:22:03Z","timestamp":1337790123000},"page":"2693-2697","source":"Crossref","is-referenced-by-count":23,"title":["Influence of Sildenafil on Genital Engorgement in Women with Female Sexual Arousal Disorder"],"prefix":"10.1093","volume":"9","author":[{"given":"Laura S.","family":"Leddy","sequence":"first","affiliation":[{"name":"University of Washington , Seattle, WA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire C.","family":"Yang","sequence":"additional","affiliation":[{"name":"University of Washington , Seattle, WA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwyn G.","family":"Stuckey","sequence":"additional","affiliation":[{"name":"Keogh Institute for Medical Research , Nedlands, WA , Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Sudworth","sequence":"additional","affiliation":[{"name":"Pfizer Inc. , Sandwich , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Haughie","sequence":"additional","affiliation":[{"name":"Pfizer, Inc. , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Sultana","sequence":"additional","affiliation":[{"name":"Pfizer, Inc. , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth R.","family":"Maravilla","sequence":"additional","affiliation":[{"name":"University of Washington , Seattle, WA , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,10,1]]},"reference":[{"key":"2024032600380410500_bb0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.ju.0000146643.00140.e3","article-title":"Noncontrast dynamic magnetic resonance imaging for quantitative assessment of female sexual arousal","volume":"173","author":"Maravilla","year":"2005","journal-title":"J Urol"},{"key":"2024032600380410500_bb0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/01674820400002220","article-title":"MRI of female genital and pelvic organs during sexual arousal","volume":"25","author":"Suh","year":"2004","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"2024032600380410500_bb0020","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-5347(05)67828-7","article-title":"Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications","volume":"163","author":"Basson","year":"2000","journal-title":"J Urol"},{"key":"2024032600380410500_bb0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.ijir.3901625","article-title":"Influence of PDE5 inhibitor on MRI measurement of clitoral volume response in women with FSAD: A feasibility study of a potential technique for evaluating drug response","volume":"20","author":"Yang","year":"2008","journal-title":"Int J Impot Res"},{"key":"2024032600380410500_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1002729318254","article-title":"Prevalence of sexual dysfunctions: Results from a decade of research","volume":"30","author":"Simons","year":"2001","journal-title":"Arch Sex Behav"},{"key":"2024032600380410500_bb0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0090-4295(02)01663-1","article-title":"Type 5 phosphodiesterase expression in the human vagina","volume":"60","author":"D\u2019Amati","year":"2002","journal-title":"Urology"},{"key":"2024032600380410500_bb0040","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.urology.2005.11.055","article-title":"Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: Immunohistochemical and molecular biology study","volume":"67","author":"Oelke","year":"2006","journal-title":"Urology"},{"key":"2024032600380410500_bb0045","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/j.1743-6109.2007.00595.x","article-title":"Expression of messenger ribonucleic acid encoding for phosphodiesterase isoenzymes in human female genital tissues","volume":"4","author":"Uckert","year":"2007","journal-title":"J Sex Med"},{"key":"2024032600380410500_bb0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00005392-199707000-00020","article-title":"Immunohistochemical description of nitric oxide synthase isoforms in human clitoris","volume":"158","author":"Burnett","year":"1997","journal-title":"J Urol"},{"key":"2024032600380410500_bb0055","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrurol.2009.25","article-title":"Sildenafil citrate for female sexual arousal disorder: A future possibility?","volume":"6","author":"Schoen","year":"2009","journal-title":"Nat Rev Urol"},{"key":"2024032600380410500_bb0060","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1023\/A:1019848310142","article-title":"Psychologic treatments for female sexual dysfunction: Are they effective and do we need them?","volume":"31","author":"Heiman","year":"2002","journal-title":"Arch Sex Behav"},{"key":"2024032600380410500_bb0065","first-page":"623","article-title":"Premenopausal women affected by sexual arousal disorder treated with sildenafil: A double-blind, cross-over, placebo-controlled study","volume":"108","author":"Caruso","year":"2001","journal-title":"BJOG"},{"issue":"6 Pt 1","key":"2024032600380410500_bb0070","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1097\/01.ju.0000090966.74607.34","article-title":"Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: A double-blind, placebo controlled study","volume":"170","author":"Berman","year":"2003","journal-title":"J Urol"},{"key":"2024032600380410500_bb0075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/152460902317586001","article-title":"Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder","volume":"11","author":"Basson","year":"2002","journal-title":"J Womens Health Gend Based Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515337577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515337577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/10\/2693\/47770698\/jsm_9_10_2693.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/10\/2693\/47770698\/jsm_9_10_2693.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:31:58Z","timestamp":1711416718000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/9\/10\/2693\/6886936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,1]]},"references-count":14,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2012,10,1]]},"published-print":{"date-parts":[[2012,10,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2012.02796.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,10]]},"published":{"date-parts":[[2012,10,1]]}}}